Cancer Center of Kansas - McPherson
Mcpherson, Kansas, United States
Cancer treatment center in McPherson, Kansas
1000 Hospital Dr, McPherson, KS 67460
About Cancer Center of Kansas - McPherson
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
69
SWOG Cancer Research Network
31
Alliance for Clinical Trials in Oncology
24
ECOG-ACRIN Cancer Research Group
11
Gynecologic Oncology Group
6
Eastern Cooperative Oncology Group
4
GOG Foundation
3
NSABP Foundation Inc
3
NRG Oncology
2
ETOP IBCSG Partners Foundation
1
Wake Forest University Health Sciences
1
Clinical Trials at Cancer Center of Kansas - McPherson
During the past decade, Cancer Center of Kansas - McPherson conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 92 clinical trials were completed, i.e. on
average, 191.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 44 clinical trials were completed. i.e. 733.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma
2003-09-01
2011-07-01
Completed
57
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-12-17
2025-12-01
Active, not recruiting
3,066
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
2004-02-01
2012-11-01
Completed
3,397
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
2006-03-24
2013-02-02
Completed
115
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
2007-12-01
2015-10-01
Completed
94
Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection
2006-06-01
2017-06-15
Completed
568
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
2008-02-25
Active, not recruiting
165
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Cancer Center of Kansas - McPherson" #1 sponsor was "National Cancer Institute (NCI)" with 69 trials, followed by "SWOG Cancer Research Network" with 31 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 24 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 11 trials sponsored and "Gynecologic Oncology Group"
with 11 trials sponsored. Other sponsors include 9 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Center of Kansas - McPherson"
#1 collaborator was "National Cancer Institute (NCI)" with 86 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 3 trials as a collaborator and "SWOG Cancer Research Network" with 3 trials as a collaborator. Other collaborators include 19 different institutions and companies that were
collaborators in the rest 25 trials.
Clinical Trials Conditions at Cancer Center of Kansas - McPherson
According to Clinical.Site data, the most researched conditions in "Cancer Center of Kansas - McPherson" are
"Breast Cancer" (11 trials), "Invasive Breast Carcinoma" (6 trials), "Recurrent Breast Carcinoma" (6 trials), "Stage IV Cutaneous Melanoma AJCC v6 and v7" (6 trials) and "Colorectal Cancer" (5 trials). Many other conditions were trialed in "Cancer Center of Kansas - McPherson" in a lesser frequency.
Clinical Trials Intervention Types at Cancer Center of Kansas - McPherson
Most popular intervention types in "Cancer Center of Kansas - McPherson" are "Drug" (120 trials), "Other" (98 trials), "Biological" (55 trials), "Procedure" (33 trials) and "Radiation" (16 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (56 trials), "Quality-of-Life Assessment" (33 trials), "Paclitaxel" (19 trials), "Carboplatin" (18 trials) and "Questionnaire Administration" (15 trials). Other intervention names were less common.
Clinical Trials Genders at Cancer Center of Kansas - McPherson
The vast majority of trials in "Cancer Center of Kansas - McPherson" are
124 trials for "All" genders, 30 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Cancer Center of Kansas - McPherson
Currently, there are NaN active trials in "Cancer Center of Kansas - McPherson".
undefined are not yet recruiting,
18 are recruiting,
67 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 57 completed trials in Cancer Center of Kansas - McPherson,
1 suspended trials,
and 8 terminated clinical trials to date.
Out of the total trials that were conducted in Cancer Center of Kansas - McPherson, 6 "Phase 1"
clinical trials were conducted, 76 "Phase 2" clinical
trials and 70 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 5 trials that are defined as “Not Applicable".